Switzerland
Medical Affairs-oriented professional with experience across Medical Information, Scientific Communications, and cross-functional oncology teams in high-growth environments. Demonstrated contribution to launch readiness, and evidence communication across hematology and solid tumors. Strong focus on translating data into actionable insights, driving digital innovation, and contributing to cross-functional decision-making in complex, multi-regional environments.
- Leading Medical Information activities across MEA and France and supporting EMEA more broadly, serving as secondary EU lead and acting EU lead during 6-month maternity leave coverage. - Built and strengthened cross-regional and cross-functional partnerships. - Contribute to MCBS/ESMO submission strategy, supporting evidence packages and informing publication strategy in collaboration with HEOR and MA teams; led development of an ESMO MCBS scorecard analysis tool. - Supported major congresses (ESMO, EHA), contributing to scientific exchange and dissemination of medical evidence. - Acted as Solid Tumor SME and Medical Information representative on regional Medical Review Committees, contributing to scientific review and decision-making; served as secondary Heme lead - Supported Health Authority inspections and pharmacovigilance audits across multiple regions, ensuring compliance and operational readiness - Supported regional launch activities across Europe and MEA including capability building, onboarding, and knowledge dissemination for local teams and partners. - Maintained regular collaboration with external partners (e.g., PPD) to improve request handling and service quality, and contributed to streamlining departmental activities. - Supported global medical information operations, including escalations and content development - Drive digital and AI-enabled innovation initiatives, including the development of data-driven insights tools leveraging medical information data to inform Medical Affairs decision-making. - Contributed to the company name change across the Medical Information website and digital assets. - Ideated and project lead for the delivery of an AI-enabled one-stop shop for the Scientific Communications department, and contribution to ongoing improvements in MI systems - Consistently achieved strong performance ratings and recognized for initiative, entrepreneurial mindset, and cross-functional collaboration.
- Sequentially expanded regional responsibilities across APAC, MEA, and EU, including EU leadership during 5-month maternity leave coverage. - Supported APAC launch readiness activities, working closely with ANZ and South Korean teams across Medical Affairs and Commercial, including PRC and MRC discussions and reviews. - Served as the Solid Tumor medical information reviewer on the Region Europe Medical Review Committee - Served as liaison to French responsible pharmacist on medical information service issues and creation of local working instructions to comply with French law - Built and strengthened cross-regional and cross-functional partnerships, supporting collaboration across Medical Affairs, Commercial, and regional teams - Co-led digital and systems initiatives to enhance medical information delivery and operational efficiency - Maintained regular collaboration with external partners (e.g., PPD) to improve request handling and service quality. - Responded to escalated Heme and Solid Tumors medical information questions from global and local contact centers - Perform routine quality assurance reviews of contact center responses on the product - Created, updated, and reviewed standard response letters and other MI assets for global and local use - Staffed medical information exhibit booths at professional society meetings (ESMO) - Ensured the quality and currency of medical information SOPs and work instructions
- Collaborate with cross-functional teams and external experts to assess assets' value proposition and deliver multichannel strategy to support oncology portfolio (13 assets, Solid Tumors and Heme, supported 5 launches) - Supported multichannel evidence dissemination (social media, digital supports, congresses, webinar and workshops) , and creation and delivery of internal and external medical education materials; coordinating with providers and agencies to ensure timely and on-budget delivery of objectives. - Supported the collection of business insights to assess the success of communications strategies and plan improvements; explored novel channels and digital initiatives. - Supported international medical congresses activities (ASCO, ESMO, EHA, AMP, AGBT...), satellite symposia, workshops, webinars, corporate and investors meetings (PMWC, J.P. Morgan Healthcare Conference)
- Developed, harmonized, and reviewed technical, medical, and scientific content (flyers, datasheets, training materials, white paper, abstracts and customer-facing presentations) for solid tumor and hematological malignancies portfolio; supported international medical congresses activities
- Developed, maintained, and planned global medical responses for two GSK products, with expertise in vaccines (immunology, efficacy, safety, and epidemiology) to deliver accurate, compliant information to HCPs - Critically analyzed clinical data, guidelines, and product information to address complex medical requests - Led the development of a global MI insights database (~1M requests) to generate insights and support Global Medical Affairs strategy, contributing to automation of data extraction, reporting, and visualization - Collaborated in a matrix environment across Medical Affairs, PV, Regulatory, Clinical, and Publications teams, supporting medical communications strategy - Contributed to operational transformation and digital innovation, including call center transition, AI-driven MI tools, and implementation of systems (Veeva Vault, SFSC, WISDOM) - Supported company-wide initiatives, including voice-of-customer insights, training of medical and call center staff, and development of infographics and digital materials
- Doctor of Pharmacy (Pharm.D.) thesis: CRISPR/Cas9 – history, methods, and applications - Developed a clinical intelligence tool based on a proprietary algorithm
- Supported tislelizumab SC launch and Annual Medical Strategic Plan (AMP), along with advisory boards, congress activities, and presentation reviews; developed medical education materials and lay summaries, supported field training and MSL presentations, and contributed to abstract writing/translation, scientific literature review, and competitor analysis